Affiliation:
1. Departments of Molecular Genetics and Microbiology, and Pediatrics (Division of Genetics), University of Florida College of Medicine, Gainesville, FL
Abstract
Neurofibromatosis 1 is a progressive autosomal dominant condition caused by mutations in the NFI gene on chromosome 17. The condition shows clinical variable expressivity, with varying features even between family members who share the same mutation. Furthermore, it is impossible to precisely predict the severity and course of the condition, a source of frustration for families and physicians. Neurofibromatosis 1 is also heterogeneous at the mutation level, with more than 300 independent mutations having been reported in this gene. The mutation data have accumulated slowly owing to the variability of the mutation types and the size and complexity of the gene. This is also reflected in the lack of a simple, inexpensive, highly accurate DNA-based test for neurofibromatosis 1 at present. This article reviews current NF1 mutation spectrum and testing, discussing and illustrating mutation mechanisms and pathogenetic effects, as well as factors affecting DNA testing and interpretation/diagnosis. (J Child Neurol 2002;17:555-561).
Subject
Clinical Neurology,Pediatrics, Perinatology, and Child Health
Reference44 articles.
1. Friedman JM, Riccardi VM: Clinical and epidemiological features, in Friedman JM, Gutmann DH, MacCollin M, Riccardi VM (eds): Neurofibromatosis: Phenotype, Natural History, and Pathogenesis, 3rd ed. Baltimore , Johns Hopkins Press, 1999, 29-86.
2. Review Article : Neurofibromatosis 1: Clinical Manifestations and Diagnostic Criteria
3. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations
4. Type 1 Neurofibromatosis Gene: Identification of a Large Transcript Disrupted in Three NF1 Patients
5. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献